메뉴 건너뛰기




Volumn 65, Issue 3, 1998, Pages 159-166

What internists should know about amiodarone

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CHOLESTEROL; CORTICOSTEROID; DIGOXIN; PLACEBO; PROCAINAMIDE; QUINIDINE; WARFARIN;

EID: 2642670288     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.65.3.159     Document Type: Review
Times cited : (7)

References (30)
  • 1
    • 0027405416 scopus 로고
    • Additional antianginal efficacy of amiodarone in patients with limiting angina pectoris
    • Meyer JB, Amann FW. Additional antianginal efficacy of amiodarone in patients with limiting angina pectoris. Am Heart J 1993; 125:996-1001.
    • (1993) Am Heart J , vol.125 , pp. 996-1001
    • Meyer, J.B.1    Amann, F.W.2
  • 3
    • 0028918749 scopus 로고
    • Amiodarone: Reevaluation of an old drug
    • Podrid PJ. Amiodarone: Reevaluation of an old drug. Ann Intern Med 1995; 122:689-700.
    • (1995) Ann Intern Med , vol.122 , pp. 689-700
    • Podrid, P.J.1
  • 4
    • 0027527344 scopus 로고
    • Pharmacokinetics of amiodarone: Implications for drug therapy
    • Roden DM. Pharmacokinetics of amiodarone: implications for drug therapy. Am J Cardiol 1993; 72:45F-50F.
    • (1993) Am J Cardiol , vol.72
    • Roden, D.M.1
  • 5
    • 0023158384 scopus 로고
    • Amiodarone
    • Mason JW. Amiodarone. N Engl J Med 1987; 316:455-466.
    • (1987) N Engl J Med , vol.316 , pp. 455-466
    • Mason, J.W.1
  • 7
    • 0030635803 scopus 로고    scopus 로고
    • Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone
    • Tielman RG, Gosselink ATM, Crijns H JGM, et al. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997; 79:53-57.
    • (1997) Am J Cardiol , vol.79 , pp. 53-57
    • Tielman, R.G.1    Gosselink, A.T.M.2    Crijns, H.J.G.M.3
  • 9
    • 0031468254 scopus 로고    scopus 로고
    • Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
    • Daoud EG, Strickberger SA, Ching Man K, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337:1785-1791.
    • (1997) N Engl J Med , vol.337 , pp. 1785-1791
    • Daoud, E.G.1    Strickberger, S.A.2    Ching Man, K.3
  • 10
    • 0020526130 scopus 로고
    • Risk stratification and survival after myocardial infarction
    • The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309:331-336.
    • (1983) N Engl J Med , vol.309 , pp. 331-336
  • 11
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial
    • Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-788.
    • (1991) N Engl J Med , vol.324 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3
  • 12
    • 0026752875 scopus 로고
    • Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial 2 Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327:227-233.
    • (1992) N Engl J Med , vol.327 , pp. 227-233
  • 14
    • 0031029373 scopus 로고    scopus 로고
    • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
    • Cairns JA, Connolly SJ, Roberts R, Gent M, for the CAMIAT investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349:675-682.
    • (1997) Lancet , vol.349 , pp. 675-682
    • Cairns, J.A.1    Connolly, S.J.2    Roberts, R.3    Gent, M.4
  • 15
    • 0031038213 scopus 로고    scopus 로고
    • Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
    • Julian DG, Camm AJ, Frangin G et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349:667-674.
    • (1997) Lancet , vol.349 , pp. 667-674
    • Julian, D.G.1    Camm, A.J.2    Frangin, G.3
  • 16
    • 0027998462 scopus 로고
    • Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
    • Doval HC, Nul DR, Granecelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344:493-498.
    • (1994) Lancet , vol.344 , pp. 493-498
    • Doval, H.C.1    Nul, D.R.2    Granecelli, H.O.3    Perrone, S.V.4    Bortman, G.R.5    Curiel, R.6
  • 17
    • 0029004921 scopus 로고
    • Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrythmia
    • Singh SN, Fletcher RD, Fisher S, et al, for the CHF STAT investigators. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrythmia. N Engl J Med 1995; 333:77-82.
    • (1995) N Engl J Med , vol.333 , pp. 77-82
    • Singh, S.N.1    Fletcher, R.D.2    Fisher, S.3
  • 18
    • 0030040949 scopus 로고    scopus 로고
    • Amiodarone in congestive heart failure: Unravelling the GESICA and CHF STAT differences
    • Hammill SC, Packer DL. Amiodarone in congestive heart failure: unravelling the GESICA and CHF STAT differences (editorial). Heart 1996; 75:6-7.
    • (1996) Heart , vol.75 , pp. 6-7
    • Hammill, S.C.1    Packer, D.L.2
  • 19
    • 0006918490 scopus 로고    scopus 로고
    • Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
    • Moss AJ, Hall WJ, Cannom DS, et al, for the MADIT investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940.
    • (1996) N Engl J Med , vol.335 , pp. 1933-1940
    • Moss, A.J.1    Hall, W.J.2    Cannom, D.S.3
  • 20
    • 0024510765 scopus 로고
    • Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
    • Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989; 13:442-449.
    • (1989) J Am Coll Cardiol , vol.13 , pp. 442-449
    • Herre, J.M.1    Sauve, M.J.2    Malone, P.3    Griffin, J.C.4    Helmy, I.5    Langberg, J.J.6
  • 21
    • 85085276474 scopus 로고
    • Randomised antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
    • The CASCADE investigators. Randomised antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol 1993; 72:70F-74F.
    • (1993) Am J Cardiol , vol.72
  • 22
    • 9844224486 scopus 로고    scopus 로고
    • A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal arrhythmias
    • The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal arrhythmias. N Engl J Med 1997; 337:1576-1583.
    • (1997) N Engl J Med , vol.337 , pp. 1576-1583
  • 23
    • 0023881507 scopus 로고
    • Amiodarone pulmonary toxicity.Recognition and pathogenesis
    • Martin WJ 2d, Rosenow EC 3d. Amiodarone pulmonary toxicity.Recognition and pathogenesis.Chest 1988; 93:1067-64.
    • (1988) Chest , vol.93 , pp. 1067-1164
    • Martin Jr., W.J.1    Rosenow III, E.C.2
  • 24
    • 0025288230 scopus 로고
    • Clinical features of amiodarone-induced pulmonary toxicity
    • Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82:51-59.
    • (1990) Circulation , vol.82 , pp. 51-59
    • Dusman, R.E.1    Stanton, M.S.2    Miles, W.M.3
  • 25
    • 0025966135 scopus 로고
    • Side effects from amiodarone
    • Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J 1991; 121:158-171.
    • (1991) Am Heart J , vol.121 , pp. 158-171
    • Wilson, J.S.1    Podrid, P.J.2
  • 26
    • 0031017068 scopus 로고    scopus 로고
    • Effects of amiodarone on thyroid function
    • Harjai KT, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126:63-73.
    • (1997) Ann Intern Med , vol.126 , pp. 63-73
    • Harjai, K.T.1    Licata, A.A.2
  • 27
    • 0026069599 scopus 로고
    • An increase in plasma cholesterol independent of thyroid function during long-term amiodarone therapy
    • Wiersinga WM, Trip MD, van Beeren MH, Plomp TA, Oosting H. An increase in plasma cholesterol independent of thyroid function during long-term amiodarone therapy. Ann Intern Med 1991; 114:128-132.
    • (1991) Ann Intern Med , vol.114 , pp. 128-132
    • Wiersinga, W.M.1    Trip, M.D.2    Van Beeren, M.H.3    Plomp, T.A.4    Oosting, H.5
  • 28
    • 0020514651 scopus 로고
    • Drug interactions with amiodarone
    • Marcus FI. Drug interactions with amiodarone. Am Heart J 1983; 106:924-930.
    • (1983) Am Heart J , vol.106 , pp. 924-930
    • Marcus, F.I.1
  • 29
    • 0029801247 scopus 로고    scopus 로고
    • Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent
    • Singh BN. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Am J Cardiol 1996; 78 (suppl 4A):41-53.
    • (1996) Am J Cardiol , vol.78 , Issue.SUPPL. 4A , pp. 41-53
    • Singh, B.N.1
  • 30
    • 0026602050 scopus 로고
    • High-dose oral amiodarone loading: Electrophysiologic effects and clinical tolerance
    • Evans SJL, Myers M, Zaher C, et al. High-dose oral amiodarone loading: electrophysiologic effects and clinical tolerance. J Am Coll Cardiol 1992; 19:169-173.
    • (1992) J Am Coll Cardiol , vol.19 , pp. 169-173
    • Evans, S.J.L.1    Myers, M.2    Zaher, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.